Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Biotage AB ( (SE:BIOT) ) has provided an update.
Biotage AB has announced its decision to apply for delisting from Nasdaq Stockholm following RWK BidCo AB’s acquisition of over 90% of its shares and initiation of compulsory redemption proceedings for the remaining shares. This strategic move will be followed by an Extraordinary General Meeting on August 7, 2025, to elect new board members, signaling a significant shift in the company’s governance and market presence.
More about Biotage AB
Biotage is a global supplier and solutions partner in the fields of Drug Discovery and Development and Analytical Testing. The company specializes in separation and purification technology and intelligent workflow solutions, aiming to advance health solutions. Headquartered in Sweden, Biotage operates in over 80 countries and is listed on NASDAQ Stockholm.
Average Trading Volume: 803,741
Current Market Cap: SEK11.45B
Learn more about BIOT stock on TipRanks’ Stock Analysis page.